Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2008-01-08
2011-11-15
Kim, Alexander (Department: 1656)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C435S070100
Reexamination Certificate
active
08058027
ABSTRACT:
The invention relates to cell culture methods, kits and cell lines for producing recombinant products, e.g. therapeutic proteins and antibodies, in the presence of reduced levels of one or more contaminants and further to methods of purifying those products.
REFERENCES:
patent: 5583009 (1996-12-01), Palmiter et al.
patent: 5610053 (1997-03-01), Chung et al.
patent: 6689606 (2004-02-01), Antoniou et al.
patent: 6881556 (2005-04-01), Antoniou et al.
patent: 6949361 (2005-09-01), Antoniou et al.
patent: 6964951 (2005-11-01), Antoniou et al.
patent: 7129062 (2006-10-01), Mermond
patent: 7442787 (2008-10-01), Antoniou et al.
patent: WO94/13273 (1994-06-01), None
patent: WO95/33841 (1995-12-01), None
patent: WO98/07876 (1998-02-01), None
patent: WO00/05393 (2000-02-01), None
patent: WO/2005/065348 (2005-07-01), None
patent: WO2005/065348 (2005-07-01), None
patent: WO2008/134200 (2008-11-01), None
Figueroa et al., Enhanced cell culture performance using inducible anti-apoptotic genes E1B-19K and Aven in the production of a monoclonal antibody with Chinese hamster ovary cells, Biotechnology and Bioengineering, E. pub. Nov. 10, 2006, vol. 97, pp. 877-892.
Ohyama et al., Optimized conditions for gene transfection into the human eosinophilic cell line EoL-1 by electroporation, Journal of Immunological Methods,1998, vol. 215, pp. 105-111.
Picture of electroporation cuvettes (last viewed on Aug. 13, 2010).
Catzel et al., Purification of recombinant human growth hormone from CHO cell culture supernatant by Gradiflow preparative electrophoresis technology, Protein Expression and Purification, Nov. 2003, vol. 32, Issue 1, pp. 126-134.
Williams et al., CpG—island fragments from the HNRPA2B1/CBX3 genomic locus reduce silencing and enhance transgene expression from the hCMV promoter/enhancer in mammalian cells., BMC Biotechnology, Jun. 3, 2005, vol. 5:17, pp. 1-9.
Peter Gunning et al., A human β-actin expression vector system directs high-level accumulation of antisense transcripts, Proc. Natl. Acad. Sci, vol. 84, pp. 4831-4835, Jul. 1987.
M. Garidiner-Garden et al., CpG Islands in Vertebrate Genomes, J. Mol. Biol. 196, 261-282, 1987.
Bonifer, “Long-distance chromatin mechanisms controlling tissue-specific gene locus activation”, Gene, 238(2):277-289, Oct. 1999.
Anderson, “Human gene therapy”, Nature, 392(Supp):25-30, Apr. 1998.
Verma et al., “Gene therapy-promises, problems and prospects”, Nature, 389:239-242, Sep. 1997.
Corcoran et al., “High-level regulated expression of the human G6PD gene in transgenic mice”, Gene, 173(2):241-246, Sep. 1996.
Biamonti et al., “Two homologous genes, originated by duplication, encode the human hnRNP proteins A2 and A1”, Nucl. Acids Res., 22(11):1996-2002, Jun. 1994.
Genbank Accession No. U09120, National Library of Medicine, accessed by PTO, Jul. 5, 2000, Dec. 1994.
Genbank Accession No. D28877, National Library of Medicine, accessed by PTO, Jul. 5, 2000, Feb. 1999.
Genbank Accession No. AL031259, version AL031259.7 GI:3676176, accessed by PTO, Jul. 13, 2000, Sep. 1998.
Chalut et al., “Genomic structure of the human TATA-box-binding protein (TBP)”, Gene, 161 (2):277-282, Aug. 1995.
Foulds et al., “Analysis of the human TATA binding protein promoter and identification of an Ets site critica for activity”, Nucl. Acids Res., 25(12):2485-2494, Jun. 1997.
Li et al, “Locus control regions: coming of age at a decade plus”, Trends in Genetics, 15(10):403-408, Oct. 1999.
Chung et. al.; Characterization of the chicken β-globin insulator, 1997, Proc. Natl. Acad. Sci. vol. 94: 575-580.
Crane-Robinson, C. et al., “Chromosomal mapping of core histone acetylation by immunoselection,” Methods, 1997, 12(1), 48-56 (summary only).
DiBartolomeis, S.M. et al., “A superfamily ofDrosophilasatellite related (SR) DNA repeats restricted to the X chromosome euchromatin,” Nucl. Acids Res., 1992, 20(5), 1113-1116.
Duhig, T. et al., “The Human Surfeit Locus,” Genomics, 1998, 52, 72-78.
Ellis, J. et al., “A dominant chromatin-opening activity in 5′ hypersensitive site 3 of the human β-globin locus control region,” EMBO J., 1996, 15(3), 562-568.
Ellis, J. et al., “Evaluation of β-globin gene therapy constructs in single copy transgenic mice,” Nucl. Acids Res., 1997, 26(6), 1296-1302.
Gaston, K. et al., “CpG methylation has differential effects on the binding of YY1 and ETS proteins to the bi-directional promotor of the Surf-1 and Surf-2 genes,” Nucl. Acids Res., 1995, 23(6), 901-909.
Gaston, K. et al., “YY1 is involved in the regulation of the bi-directional promotor of the Surf-1 and Surf-2 genes,” FEBS Letts., 1994, 347, 289-294.
Garson, K. at al., “Surf5: A Gene in the Tightly Clustered Mouse Surfeit Locus is Highly Conserved and Transcribed Divergently from the rpL7a (Surf 3) Gene,” Genomics, 1996, 30, 163-170.
Gavalas, A. et al., “Analysis of the chicken GPAT/AIRC bidirectional promoter for de novo purine nucleotide synthesis,” J. Biol. Chem., 1995, 270(5), 2403-2410.
Lavia, P. et al., “Coincident start sites for divergent transcripts at a randomly selected CpG-rich island of mouse,” EMBO J., 1987, 6, 2773-2779.
Ortiz, B.D. et al., “Adjacent DNA elements dominantly restrict the ubiquitous activity of a novel chromatin-opening region to specific tissues,” EMBO J., 1997, 16, 5037-5045.
Palmiter, “The elusive function of metallothioneins,” Proc. Natl. Acad. Sci. USA, 1998, 95, 8428-8430.
Talbot, D. et al., “The 5′ flanking region of the rat LAP (C/EBPβ) gene can direct high-level, position-independent, copy number-dependent expression in multiple tissues in transgenic mice,” Nucl. Acids Res., 1994, 22(5), 756-766.
Williams, T.J. et al., “The MES-1 Murine Enhancer Element is Closely Associated with the Heterogeneous 5′ Ends of Two Divergent Transcription Units,” Mol. Cell. Biol., 1986, 6(12), 4558-4569.
Winston, J. H. et al., “An intron 1 regulatory region from the murine adenosine deaminase gene can activate heterologous promoters for ubiquitous expression in transgenic mice,” Som. Cell Mol. Genet., 1996, 22, 261-278.
Festenstein, R., et al., “Locus control region function and heterochromatic-induced position effect variegation,” Science, 1996, 271(23), 1123-1125.
Gavalas, A., et al., “Coexpression of two closely linked avian genes for purine nucleotide synthesis from a bidirectional promoter,” Mol. Cell Biol., 1983, 13(8), 4784-4792.
Huxley, C., et al., “The mouse surfeit locus contains a cluster of six genes associated with four Gp G-rich islands in 32 kilobases of genomic DNA,” Mol. Cell Biol., 1990, 10(2), 605-614.
Ohbayashi, T., et al., “Promoter structure of the mouse TATA-binding protein (TBP) gene,” Biochem. Biophys. Res. Commun., 1996, 225(1), 275-280.
Ryan M.T., et al., “The genes encoding mammalian chaperonin 60 and chaperonin 10 are linked head-to-head and share a bidirectional promoter,” Gene: An International J on Genes and Genomes, 1997, 196(1-2), 9-17.
Ursini, et al., 1990, High levels of transcription driven by a 400 by segment of the human G6PD promotor, Biochem. Biophys. Res. Commun., 170:1203-1209.
Shewchuk and Hardison, “CpG Islands from the α-Globin Gene Cluster Increase Gene Expression in an Integration-Dependend Manner,” Molecular and Cellular Biology. Oct. 1997, 17(10):5856-5866.
Larsen, F. et al., “CpG Islands as Gene Markers in the Human Genome,” Genomics, 1992, 13:1095-1107.
Pikaart, Michael J., “Loss of transcriptional activity of a transgene is accompanied by DNA methylation and histone deacetylation and is prevented by insulators,” Genes and Development, 1998, 12:2852-2862.
Recillas-Targa, F. et al., “Positional enhancer-blocking activity of the chicken β-g
Kim Alexander
Millipore Corporation
LandOfFree
Cell culture methods for producing recombinant proteins in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cell culture methods for producing recombinant proteins in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cell culture methods for producing recombinant proteins in... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4295780